Staat Mary Allen, Meinzen-Derr Jareen, Welch Timothy, Roberts Nancy E, Jamison Linda, Gerber Michael A, Morrow Ardythe L
Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Pediatrics. 2006 May;117(5):e833-9. doi: 10.1542/peds.2004-2412.
The American Academy of Pediatrics recommended routine use of varicella vaccine in pediatric practice in 1995. We examined the impact of varicella immunization on population-based rates of pediatric varicella-related hospitalizations and emergency department (ED) visits in the years before and after introduction of varicella vaccine.
Discharge data for hospitalizations and ED encounters from 1990 through 2003 were queried for patients <20 years of age with varicella International Classification of Diseases, Ninth Revision, Clinical Modification codes (052.0-052.9) in any diagnostic position. Addresses were geocoded for identification of Hamilton County, Ohio, residents. Rates were calculated according to year, age, and race, with census estimates.
During the 14-year study period, there were 3983 incident varicella cases; 335 patients were hospitalized and 3833 were treated only in the ED. The rate of varicella-related hospitalizations decreased from 15.7 cases per 100,000 population to 5.5 cases per 100,000 population between the prevaccine period (1990-1995) and the postvaccine period (1996-2003); varicella-related ED use decreased from 178.2 cases per 100,000 population to 61.2 cases per 100,000 population. In the prevaccine period, hospitalization and ED visit rates were significantly higher for black children than for white children. In the postvaccine period, hospitalization rates did not differ according to race but ED visit rates remained significantly higher for black children, compared with white children.
Varicella-related hospitalization and ED visit rates decreased significantly for both white and black children in Hamilton County, Ohio, after the introduction of varicella vaccine, and the racial disparity found before licensure decreased after licensure.
美国儿科学会于1995年建议在儿科医疗实践中常规使用水痘疫苗。我们研究了在引入水痘疫苗前后几年中,水痘免疫接种对基于人群的儿科水痘相关住院率和急诊科(ED)就诊率的影响。
查询了1990年至2003年期间住院和急诊就诊的出院数据,以获取年龄小于20岁且在任何诊断位置有国际疾病分类第九版临床修订本(ICD-9-CM)水痘编码(052.0 - 052.9)的患者。对地址进行地理编码以识别俄亥俄州汉密尔顿县的居民。根据年份、年龄和种族,并结合人口普查估计数计算发病率。
在14年的研究期间,有3983例水痘确诊病例;335例患者住院,3833例仅在急诊科接受治疗。在疫苗接种前时期(1990 - 1995年)和疫苗接种后时期(1996 - 2003年)之间,水痘相关住院率从每10万人口15.7例降至每10万人口5.5例;水痘相关的急诊科就诊率从每10万人口178.2例降至每10万人口61.2例。在疫苗接种前时期,黑人儿童的住院率和急诊科就诊率显著高于白人儿童。在疫苗接种后时期,住院率在不同种族间没有差异,但与白人儿童相比,黑人儿童的急诊科就诊率仍然显著更高。
在俄亥俄州汉密尔顿县引入水痘疫苗后,白人和黑人儿童的水痘相关住院率和急诊科就诊率均显著下降,并且在疫苗获批前发现的种族差异在获批后有所减少。